Picture of Anika Therapeutics logo

ANIK Anika Therapeutics Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual cashflow statement for Anika Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line4.13-14.9-82.7-56.4-10.9
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items3.6521.985.166.517.2
Unusual Items
Other Non-Cash Items
Changes in Working Capital-11.9-11.8-12.1-13.1-0.823
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Cash from Operating Activities8.44.41-1.795.411.2
Capital Expenditures-5.14-7.49-5.43-8.33-6.83
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items2.02006.42
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-3.12-7.49-5.43-8.33-0.401
Financing Cash Flow Items-7.71-4.58-1.35-1.89-1.07
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-6.78-4.85-6.32-12.7-10.6
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.43-8.06-13.5-15.70.322